These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8043858)

  • 1. Loss of membrane-dependent factor Va cleavage: a mechanistic interpretation of the pathology of protein CVermont.
    Lu D; Kalafatis M; Mann KG; Long GL
    Blood; 1994 Aug; 84(3):687-90. PubMed ID: 8043858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of inactivation of human factor V and human factor Va by activated protein C.
    Kalafatis M; Rand MD; Mann KG
    J Biol Chem; 1994 Dec; 269(50):31869-80. PubMed ID: 7989361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
    Egan JO; Kalafatis M; Mann KG
    Protein Sci; 1997 Sep; 6(9):2016-27. PubMed ID: 9300501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical prototype for familial thrombosis. A study combining a functional protein C mutation and factor V Leiden.
    Kalafatis M; Lu D; Bertina RM; Long GL; Mann KG
    Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2181-7. PubMed ID: 7489240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals.
    Camire RM; Kalafatis M; Cushman M; Tracy RP; Mann KG; Tracy PB
    J Biol Chem; 1995 Sep; 270(35):20794-800. PubMed ID: 7657663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the molecular defect in factor VR506Q.
    Kalafatis M; Bertina RM; Rand MD; Mann KG
    J Biol Chem; 1995 Feb; 270(8):4053-7. PubMed ID: 7876154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C.
    Nicolaes GA; Tans G; Thomassen MC; Hemker HC; Pabinger I; Varadi K; Schwarz HP; Rosing J
    J Biol Chem; 1995 Sep; 270(36):21158-66. PubMed ID: 7673148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V.
    Lu D; Kalafatis M; Mann KG; Long GL
    Blood; 1996 Jun; 87(11):4708-17. PubMed ID: 8639840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance assay.
    Kalafatis M; Haley PE; Lu D; Bertina RM; Long GL; Mann KG
    Blood; 1996 Jun; 87(11):4695-707. PubMed ID: 8639839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells.
    Hockin MF; Kalafatis M; Shatos M; Mann KG
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2765-75. PubMed ID: 9409254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the membrane in the inactivation of factor Va by activated protein C.
    Kalafatis M; Mann KG
    J Biol Chem; 1993 Dec; 268(36):27246-57. PubMed ID: 8262965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va.
    Norstrøm EA; Steen M; Tran S; Dahlbäck B
    J Biol Chem; 2003 Jul; 278(27):24904-11. PubMed ID: 12707283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin.
    Segers K; Dahlbäck B; Rosing J; Nicolaes GA
    J Biol Chem; 2008 Aug; 283(33):22573-81. PubMed ID: 18519572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
    Rosing J; Hoekema L; Nicolaes GA; Thomassen MC; Hemker HC; Varadi K; Schwarz HP; Tans G
    J Biol Chem; 1995 Nov; 270(46):27852-8. PubMed ID: 7499257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage at both Arg306 and Arg506 is required and sufficient for timely and efficient inactivation of factor Va by activated protein C.
    Barhoover MA; Kalafatis M
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):317-24. PubMed ID: 21467919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel APC-cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S.
    Tran S; Dahlbäck B
    J Thromb Haemost; 2010 Jan; 8(1):129-36. PubMed ID: 19874463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the membrane in the inactivation of factor va by plasmin. Amino acid region 307-348 of factor V plays a critical role in factor Va cofactor function.
    Kalafatis M; Mann KG
    J Biol Chem; 2001 May; 276(21):18614-23. PubMed ID: 11278331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The autolysis loop of activated protein C interacts with factor Va and differentiates between the Arg506 and Arg306 cleavage sites.
    Gale AJ; Heeb MJ; Griffin JH
    Blood; 2000 Jul; 96(2):585-93. PubMed ID: 10887122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C.
    Camire RM; Kalafatis M; Simioni P; Girolami A; Tracy PB
    Blood; 1998 Apr; 91(8):2818-29. PubMed ID: 9531592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiolipin enhances protein C pathway anticoagulant activity.
    Fernández JA; Kojima K; Petäjä J; Hackeng TM; Griffin JH
    Blood Cells Mol Dis; 2000 Apr; 26(2):115-23. PubMed ID: 10753602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.